124 related articles for article (PubMed ID: 12013578)
21. A cytogenetic study of 53 human gliomas.
Jenkins RB; Kimmel DW; Moertel CA; Schultz CG; Scheithauer BW; Kelly PJ; Dewald GW
Cancer Genet Cytogenet; 1989 Jun; 39(2):253-79. PubMed ID: 2752377
[TBL] [Abstract][Full Text] [Related]
22. Molecular genetic analysis of oligodendroglial tumors shows preferential allelic deletions on 19q and 1p.
Reifenberger J; Reifenberger G; Liu L; James CD; Wechsler W; Collins VP
Am J Pathol; 1994 Nov; 145(5):1175-90. PubMed ID: 7977648
[TBL] [Abstract][Full Text] [Related]
23. Molecular genetic evidence for subtypes of oligoastrocytomas.
Maintz D; Fiedler K; Koopmann J; Rollbrocker B; Nechev S; Lenartz D; Stangl AP; Louis DN; Schramm J; Wiestler OD; von Deimling A
J Neuropathol Exp Neurol; 1997 Oct; 56(10):1098-104. PubMed ID: 9329453
[TBL] [Abstract][Full Text] [Related]
24. [The oligodendroglioma: the value of histologic and genetic diagnosis in predicting sensitivity to chemotherapy].
Kros JM
Ned Tijdschr Geneeskd; 2005 Jun; 149(25):1379-85. PubMed ID: 15997690
[TBL] [Abstract][Full Text] [Related]
25. Human ependymomas reveal frequent deletions on chromosomes 6 and 9.
Huang B; Starostik P; Schraut H; Krauss J; Sörensen N; Roggendorf W
Acta Neuropathol; 2003 Oct; 106(4):357-62. PubMed ID: 12898154
[TBL] [Abstract][Full Text] [Related]
26. Comparative genomic hybridization detects losses of chromosomes 22 and 16 as the most common recurrent genetic alterations in primary ependymomas.
Zheng PP; Pang JC; Hui AB; Ng HK
Cancer Genet Cytogenet; 2000 Oct; 122(1):18-25. PubMed ID: 11104027
[TBL] [Abstract][Full Text] [Related]
27. Detection of chromosomal changes by interphase cytogenetics in biopsies of recurrent astrocytomas and oligodendrogliomas.
Rosso SM; van Dekken H; Krishnadath KK; Alers JC; Kros JM
J Neuropathol Exp Neurol; 1997 Oct; 56(10):1125-31. PubMed ID: 9329456
[TBL] [Abstract][Full Text] [Related]
28. Ependymal tumors.
Hasselblatt M
Recent Results Cancer Res; 2009; 171():51-66. PubMed ID: 19322537
[TBL] [Abstract][Full Text] [Related]
29. Polymorphous oligodendroglioma of Zülch revisited: a genetically heterogeneous group of anaplastic gliomas including tumors of bona fide oligodendroglial differentiation.
Hewer E; Beck J; Murek M; Kappeler A; Vassella E; Vajtai I
Neuropathology; 2014 Aug; 34(4):323-32. PubMed ID: 24444336
[TBL] [Abstract][Full Text] [Related]
30. Study of chromosome 9q gain, Notch pathway regulators and Tenascin-C in ependymomas.
Gupta RK; Sharma MC; Suri V; Kakkar A; Singh M; Sarkar C
J Neurooncol; 2014 Jan; 116(2):267-74. PubMed ID: 24178439
[TBL] [Abstract][Full Text] [Related]
31. [Towards a molecular classification of gliomas].
Hoang-Xuan K; Idbaih A; Mokhtari K; Sanson M
Bull Cancer; 2005 Apr; 92(4):310-6. PubMed ID: 15888387
[TBL] [Abstract][Full Text] [Related]
32. Histological growth patterns and genotype in oligodendroglial tumours: correlation with MRI features.
Jenkinson MD; du Plessis DG; Smith TS; Joyce KA; Warnke PC; Walker C
Brain; 2006 Jul; 129(Pt 7):1884-91. PubMed ID: 16670176
[TBL] [Abstract][Full Text] [Related]
33. Molecular pathology of oligodendroglial tumors.
Hartmann C; von Deimling A
Recent Results Cancer Res; 2009; 171():25-49. PubMed ID: 19322536
[TBL] [Abstract][Full Text] [Related]
34. Histopathological-molecular genetic correlations in referral pathologist-diagnosed low-grade "oligodendroglioma".
Sasaki H; Zlatescu MC; Betensky RA; Johnk LB; Cutone AN; Cairncross JG; Louis DN
J Neuropathol Exp Neurol; 2002 Jan; 61(1):58-63. PubMed ID: 11829344
[TBL] [Abstract][Full Text] [Related]
35. BAC array CGH distinguishes mutually exclusive alterations that define clinicogenetic subtypes of gliomas.
Idbaih A; Marie Y; Lucchesi C; Pierron G; Manié E; Raynal V; Mosseri V; Hoang-Xuan K; Kujas M; Brito I; Mokhtari K; Sanson M; Barillot E; Aurias A; Delattre JY; Delattre O
Int J Cancer; 2008 Apr; 122(8):1778-86. PubMed ID: 18076069
[TBL] [Abstract][Full Text] [Related]
36. Loss of heterozygosity on chromosome 22 in human ependymomas.
Huang B; Starostik P; Kühl J; Tonn JC; Roggendorf W
Acta Neuropathol; 2002 Apr; 103(4):415-20. PubMed ID: 11904762
[TBL] [Abstract][Full Text] [Related]
37. Hypermethylation and transcriptional downregulation of the CITED4 gene at 1p34.2 in oligodendroglial tumours with allelic losses on 1p and 19q.
Tews B; Roerig P; Hartmann C; Hahn M; Felsberg J; Blaschke B; Sabel M; Kunitz A; Toedt G; Neben K; Benner A; von Deimling A; Reifenberger G; Lichter P
Oncogene; 2007 Jul; 26(34):5010-6. PubMed ID: 17311001
[TBL] [Abstract][Full Text] [Related]
38. Ancillary FISH analysis for 1p and 19q status: preliminary observations in 287 gliomas and oligodendroglioma mimics.
Perry A; Fuller CE; Banerjee R; Brat DJ; Scheithauer BW
Front Biosci; 2003 Jan; 8():a1-9. PubMed ID: 12456321
[TBL] [Abstract][Full Text] [Related]
39. Pleomorphic xanthoastrocytoma and oligodendroglioma: collision of 2 morphologically and genetically distinct anaplastic components.
Hattab EM; Martin SE; Shapiro SA; Cheng L
J Neurosurg; 2011 Jun; 114(6):1648-53. PubMed ID: 21214337
[TBL] [Abstract][Full Text] [Related]
40. Molecular analysis of chromosome 1, 10 and 19 abnormalities in human oligodendroglial tumors: relationship between frequency of LOH grade, age and gender.
Gresner SM; Rieske P; Wozniak K; Piaskowski S; Jaskolski DJ; Skowronski W; Golanska E; Sikorska B; Liberski PP
Clin Neuropathol; 2006; 25(1):18-24. PubMed ID: 16465770
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
